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Objective: An ideal animal model of abdominal aortic aneurysm (AAA) is of great importance for clarifying unknown
complex mechanisms of the pathogenesis. We introduce a new, simple technique to create reliable AAAs that simulate
human aneurysms.
Methods: Experimental models of AAAs were created in 71 rats by means of a 20-minute application of intraluminal
elastase (30 U) and extraluminal calcium chloride (0.5M) in the 1-cm segment of infrarenal abdominal aorta (group EC,
n 26). A single application of elastase (group E, n 24) or calcium chloride (group C, n 21) was used as control. The
treated aorta in each group was measured under physiologic conditions and harvested at 1 and 4 weeks. Successful AAA
formation was defined as a dilation ratio >50%. Inflammatory response, elastolytic activity, and histology in the treated
aorta were evaluated among the three groups.
Results: The surgical procedure in each group was similarly completed for approximate 30 minutes and performed
without any technical failure or operative death. At 4 weeks, the dilation ratio and wall thickness were 94.8% 9.9% and
125.4  5.6 m in group EC, 43.3%  6.3% and 149.6  6.5 m in group E, and 10.9%  4.2% and 152.9  7.2 m
in group C. The success rate of AAA formation in group EC (92.7%) was significantly higher than that in group E (25.0%)
and group C (0.0%). Less elastin content in the aortic wall was observed in group EC. At 1 week, tumor necrosis factor-
and interleukin-1 messenger RNA (mRNA) expressions were significantly upregulated, and CD3 and CD11b cells
were significantly infiltrated into the treated aorta of group EC, compared with groups E or C. Gelatinolytic activities and
mRNA expressions of matrix metalloproteinase (MMP)-2 and MMP-9 were also significantly activated in group EC.
Conclusion: The rat AAA model using a combination of intraluminal elastase infusion and extraluminal calcium chloride
exposure is simple and easy to perform and is highly reliable and reproducible to create a saccular aneurysm similar to
human AAAs. This model could be more useful to clarify AAA pathogenesis, mechanisms, and treatment interventions in
experimental researches. ( J Vasc Surg 2009;50:1423-32.)
Clinical Relevance: Abdominal aortic aneurysm (AAA) typically has a silent nature, and its rupture has high morbidity
and mortality. There are currently no therapeutic approaches to prevent AAA, and complete mechanisms of AAA
formation are still poorly understood. We developed a novel rat AAA model using a combination of intraluminal elastase
infusion and extraluminal calcium chloride exposure. This model is simple and easy to perform and is highly reliable and
reproducible to create a saccular aneurysm. It could become a powerful tool not only to elucidate etiopathogenetic
mechanisms of AAA formation but also to explore new diagnostic and therapeutic possibilities.Abdominal aortic aneurysm (AAA) is a degenerative dis-
ease characterized by destruction of aortic architecture and
subsequent dilatation. Because of its silent nature, the likely
sequelae of undiagnosed AAAs include rupture, which can be
fatal and requires emergency surgical management. Although
the main pathogenesis of AAAs is atherosclerosis, multiple
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doi:10.1016/j.jvs.2009.08.062environmental and genetic risk factors are considered to be
involved in aneurysm formation and progression.1 Previous
research has shown that various inflammatory networks con-
tribute to the AAA formation through certain signaling path-
ways to promote the degradation of extracellular matrix or
impair the biosynthesis of extracellular matrix,2-6 but com-
plete mechanisms of AAA formation are still poorly under-
stood. Therefore, establishing experimental models for the
AAA research should be of critical importance.
Several animal models have been developed to assist in
our understanding of the pathophysiologic mechanisms of
AAA formation. One of the most popular is the elastase-
induced model of AAA that was first introduced by Anidjar
et al.7 The concept for the AAA development is based on
the disrupted nature of elastin, which consists of extracel-
lular matrix in aortic walls.
Although many reports proved the efficacy of elas-
tase,8-12 Carsten et al13 indicated that this model requires a
1423
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which may result in high mortality due to an extensive
aortic elastolysis and a long hind limb ischemia. Recently,
Yamaguchi et al14 and Sinha et al15,16 have shown success-
ful rat AAAmodels with a short elastase infusion time of 30
minutes.
Another inflammatory modifier might be helpful in the
elastase-induced model to create reliable AAAs that simu-
late human aneurysms. Another popular model is the cal-
cium chloride (CaCl2)-induced AAA model that was first
reported by Gertz et al.17 Periaortic CaCl2 application
promotes inflammatory responses, followed by structural
disruption of the aortic walls that leads to the AAA devel-
opment.2 This model, however, does not always result in
sufficient aneurysmal formation. Isenburg et al18 have re-
ported that its dilatation rate is only 66.7%, even with an
arbitrary threshold of a 20% diameter increase considered as
an aneurysm.
The purposes of this study were to introduce a new rat
AAA model using a combination of intraluminal elastase
infusion and extraluminal CaCl2 exposure, with a detailed
description of surgical techniques and to evaluate the reli-
ability and reproducibility of the AAA model compared
with AAA models with a single application of elastase or
CaCl2.
MATERIALS AND METHODS
Animals. This study used 71 male Sprague-Dawley
rats (8 weeks old, CLEA Japan Inc, Tokyo). The handling
of the rats and their use in experiments conformed to the
Guidelines for Animal Experiment at Kobe University
Graduate School of Medicine and the Guide for the Care
and Use of Laboratory Animals published by the National
Fig 1. A schematic drawing shows the rat abdominal
elastase-infusion and extraluminal calcium chloride expoAcademy Press.19Anesthesia. Rats were placed in a closed chamber
containing diethyl ether (Wako, Osaka, Japan). After loss of
consciousness, the rats were anesthetized by the intraperi-
toneal administration of pentobarbiturate (1 mg/kg).
A new AAA model. Anesthetized rats were placed
under an operating microscope Leica M651 (Leica Micro-
systems, Heerbrugg, Switzerland; 6 to 10 magnifica-
tion). A long midline abdominal incision from pubis to
xiphoid was made, and the abdominal cavity was exposed.
The intestines were retracted superiorly and covered with
wet gauze to keep them moist during the operation.
The abdominal aorta was exposed below the renal
vessels. All lumbar branches of the exposed infrarenal aorta
were ligated. Through a groin incision, a SP10 polyethylene
catheter (Natsume Seisakusho, Tokyo, Japan) was inserted
into a right femoral artery and advanced in the infrarenal aorta.
An atraumatic microvascular clamp was placed on the aorta
just below the left renal vein, and a temporary ligature with
4-0 silk was placed 1 cm distal to the clamp.
The isolated region of the aorta was filled with 30 L
(30 U) of porcine pancreatic elastase (135 U/mg; Elastin
Products, Mo) through the SP10 catheter without any
aortic expansion, and gauze soaked in 0.5MCaCl2 (Sigma-
Aldrich, Tokyo, Japan) was wrapped the aorta circumfer-
entially. After 20 minutes of intraluminal static elastase
infusion and extraluminal CaCl2 exposure, the catheter was
removed and the right femoral artery was ligated. The
microvascular clamp and the temporary ligature were re-
moved from the aorta to restore blood flow.
The intestines were returned to the abdominal cavity.
The abdominal incision was closed with continuous run-
ning 5-0 nylon suture, and the rats were placed in warming
cages to recover. The schematic drawing of this AAAmodel
wrapping with a gauze 
soaked in CaCl2 (0.5M) 
filling with elastase 
(30U / 30µl)
 
aneurysm model using a combination of intraluminalaorticis shown in Fig 1.
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three groups at random according to their treatment allo-
cation as follows: 26 to intraluminal elastase infusion and
extraluminal CaCl2 exposure (group EC), 24 to intralumi-
nal elastase infusion and extraluminal vehicle (saline) expo-
sure (group E), and 21 to intraluminal vehicle (saline)
infusion and extraluminal CaCl2 exposure (group C). Ex-
cept for their treatment allocation, there were no proce-
dural differences among the three groups.
The end points of the present study were 1 and 4 weeks
after treatment in each group. The 1-week samples were
used for morphometric and molecular analyses (6 in each
group) and immunohistochemical analysis (6 in each
group). The 4-week samples were used for morphometric
and histologic analyses (14 in group EC, 12 in group E, and
9 in group C).
Macroscopic assessments. Animals were anesthe-
tized, and then the abdominal aorta was exposed and
photographed with a digital camera (Leica IC D, Leica
Microsystems). The aneurysmal diameter, defined as the
maximal dimension of the transverse minor axis of the
abdominal aorta, and the aortic diameter at the infrarenal
proximal neck site, were measured under physiologic con-
ditions with an optical micrometer by a person (Z. C.) who
was blinded to the different treatment groups. The dilation
ratio was calculated according to the following formula:
Dilation ratio (%) [(aneurysmal diameter – aortic diameter)/
aortic diameter]  100. The AAA is defined as when the
dilation ratio is 50%.20
Specimen preparation. The treated 1-cm aortic seg-
ment in each group was harvested at its study end point.
The 1-week aortic segments for molecular analysis were cut
into two equal parts transversely. One segment was used for
messenger RNA (mRNA) analysis, and the remaining part
was used for gelatin zymographic analysis. The 1-week
aortic segments for immunohistochemical analysis were
embedded in Tissue-Tek O.C.T. Compound (Sakura Fi-
netek Japan Co, Tokyo, Japan) in liquid nitrogen and
stored at80°C until needed. The 4-week aortic segments
for histologic analysis were fixed in 10% formalin, dehy-
drated in a graded ethanol bath, cleaned in xylene, and
embedded in paraffin.
Histology. Paraffin-embedded 5-m-thick sections
were stained by hematoxylin and eosin (HE) for general
appearance, elastin von Gieson (EVG) for elastin, and
picrosirius red (PSR) for collagen. Images for the sec-
tions were captured with a microscopic system (BZ-
8100, KEYENCE Co, Osaka, Japan) and assessed by
using ImageJ 1.41 software (National Institute of
Health, Bethesda, MD).
The thickness of aortic wall was measured from the
average thickness at 8 points of the cross-sectional aortic
wall in the HE-stained sections. Areas of elastin and
collagen in a cross-sectional aortic wall were semiquan-
tified using the ImageJ plug-in Color Counter with a
color threshold mask. Elastin content was calculated by
dividing the elastin-positive area by the cross-sectional
media area of the aortic wall, which was measured usingthe EVG-stained sections to highlight the internal elastic
lamina and external elastic lamina. Collagen content was
calculated by dividing the collagen-positive area by the
cross-sectional aortic wall area in the PSR-stained sec-
tions. Elastin and collagen contents were expressed as a
percentage.
Immunohistochemistry. Immunohistochemical stain-
ing was performed on frozen sections (5 m) by using
anti-immunoglobulin horseradish peroxidase detection kits
(BD Pharmingen, San Diego, CA) with primary antibodies
for T-lymphocyte and leukocyte markers (mouse anti-rat
CD3 and CD11b, respectively; BD Pharmingen). Diami-
nobenzidine substrate was used as a chromogen, and cell
nuclei were counterstained with hematoxylin. Positive
cell numbers were quantified by counting reactive cells in
five nonoverlapping high-power fields using the ImageJ
software.
Quantitative real-time polymerase chain reaction
analysis. Total RNA was isolated from graft samples using
an RNeasy fibrous tissue mini-kit (Qiagen, Valencia, Calif)
according to the manufacturer’s instructions. The RNA
was transcribed and amplified to complimentary DNA
(cDNA) using a high-capacity cDNA reverse-transcription
kit (Applied Biosystems, Foster City, Calif). Quantitative
real-time polymerase chain reaction (PCR) analysis for
mRNA of matrix metalloproteinases (MMP)-2, MMP-9,
tumor necrosis factor (TNF)- and interleukin (IL)-1was
performed using ABI Prism 7500 sequence detector system
(Applied Biosystems) with TaqMan universal PCR master
mix and TaqMan real-time PCR primers (Applied Biosys-
tems). The expression level of each mRNA was divided by
mRNA level of the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).
Gelatin zymography. Proteins from aortic specimens
were extracted using a buffer containing 50mM Tris-HCl
(pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.2% sodium
dodecyl sulfate, and 1mM ethylenediaminetetraacetic acid,
supplemented with protease inhibitors (20 g/mL aproti-
nin, 10 g/mL leupeptin, and 1mM phenylmethylsulfonyl
fluoride). To determine gelatinolytic activities of MMP-2
and MMP-9 in the treated aorta, gelatin-zymography kit
(Primary Cell Co, Hokkaido, Japan) was used according to
the manufacturer’s instructions. The protein concentration
was standardized with a microbicinchoninic acid protein
assay kit (Pierce, Rockford, Ill), and then protein (20 g)
was applied in each lane for the electrophoresis. Densito-
metric analysis of the lytic bands was performed by ImageJ
software.
Statistical analysis. Database management and statis-
tical analysis were performed with StatView 5.0 software
(SAS Institute Inc, Cary, NC). All values are expressed as
means standard error of the mean for the number of rats.
Comparisons among the three groups were performed
using analysis of variance with Bonferroni correction
method. Values of P 	 .05 were considered statistically
significant.
, calci
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The surgical procedure in each group required ap-
proximately 30 minutes to complete. No technical fail-
ures or deaths occurred intraoperatively. No thrombosis
formation at the infrarenal aorta was observed postoper-
atively, and all animals survived until each end-point
uneventfully.
Macroscopic assessments. Aneurysm formation was
observed at 1 and 4 weeks. Macroscopic findings are shown
in Fig 2 and the Table. According to AAA definition in the
present study, an AAA had already formed in 50% of the
Group EC
Fig 2. Photographs show aneurysmal lesions of abdom
elastase and calcium chloride; group E, elastase; group C
Table. Macroscopic assessment of abdominal aortic
aneurysms
Group
AAA formation, No. (%) Dilation ratio, %
1 week 4 weeks 1 week 4 weeks
Group
EC 3/6 (50)a 13/14 (92.7)a 51.8  3.5a 94.8  9.9a
Group
E 1/6 (16.7) 3/12 (25.0) 22.4  7.2 43.3  6.3
Group
C 0/6 (0) 0/9 (0) 3.5  3.5 10.9  4.2
C, Calcium chloride; E, endothelin; EC, elastase and calcium chloride
combined.
aP 	 .001 vs group E or Group C.animals in group EC at 1 week, and 92.7% had saccularAAAs at 4 weeks. No AAAs formed in group C, and only
25% of animals in group E showed AAAs at 4 weeks. There
were significant differences of the AAA formation at 1 and
4 weeks in group EC compared with group E or C. The
dilation ratios of the AAAs at 1 and 4 weeks were signifi-
cantly bigger in group EC than those in group E or C.
Histology. Histology of the treated aorta at 4 weeks
was assessed to evaluate aneurysm formation in each group
(Fig 3). The aortic wall thickness was 125.4  5.6 m in
group EC, 149.6  6.5 m in group E, and 152.9  7.2
m in group C. The treated aorta in group EC was dilated
with a significantly thinner wall compared with group E or
C. EVG staining showed that degeneration and disruption
of the elastic lamellae were particularly observed in group
EC. Elastin content in group EC was significantly less than
that in group C, although the difference between group EC
and E was not significant. PSR staining showed no signifi-
cant differences of collagen content among the three
groups.
Inflammatory response. Inflammation is believed to
be part of the etiology in AAA formation by direct local
production of proinflammatory cytokines such as TNF-
and IL-1, and MMPs such as MMP-2 and MMP-9.2 At 1
week, mRNA expression of TNF-, IL-1, MMP-2, and
MMP-9 in the treated aorta was significantly upregulated in
group EC compared with group E or C (Fig 4, A). Gela-
roup E Group C
aorta at 4 weeks in each group. Group EC, Combined
um chloride.G
inaltinolytic activities of MMP-2 and MMP-9 proteins in the
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Fig 3. A, Histologic findings of abdominal aortic aneurysms (AAAs) are shown at 4 weeks after staining with
hematoxylin and eosin (HE) for an assessment of aortic wall thickness, elastin von Gieson (EVG) staining for an
assessment of elastin content, and picrosirius red (PSR) staining for an assessment of collagen content in group EC. Bar,
300 m. B,Quantitative analysis is shown for the three variables.NS,Not significant. All data are expressed as mean
standard error for 14 mice in group EC (elastin and calcium chloride combined), 12 in group E (elastin only), and 9 in
group C (calcium chloride only).
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Fig 4. Protease activity and messenger RNA (mRNA) expression in abdominal aortic aneurysms at 1 week
A, Intra-aortic mRNA expression of tumor necrosis factor (TNF)-, interleukin (IL)-1, and matrix metalloproteinase
(MMP)-2 and MMP-9. B, Gelatin zymography documents gelatinolytic activities of MMP-2 and MMP-9.
C, Densitometric analysis of the MMP activities. *P 	 .0001, **P 	 0.01. NS, Not significant. All data are expressed
as mean  standard error of the mean for 6 rats per group.
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group E or C (Figs 4, B and C).
Immunohistochemistry. To observe an infiltration of
inflammatory cells in the treated aorta at 1 week, immuno-
histochemical stainings with T-lymphocyte marker (anti-
CD3) and leukocyte marker (anti-CD11b) were per-
formed. T-lymphocytes and leukocytes tended to infiltrate
in the adventitia and outer media of the treated aortas in all
groups. The numbers of infiltrating CD3
 and CD11b

cells were significantly increased in group EC compared
with group E or C (Fig 5).
DISCUSSION
This study detailed a new method for creating AAAs
using a combination of intraluminal elastase infusion and
extraluminal CaCl2 exposure in rats and showed that this is
a reliable and reproducible saccular aneurysm model with
(1) dilated and thin aortic walls, (2) increased degradation
of elastin, (3) upregulated expressions and activities of
CD 3
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Fig 5. Inflammatory cell infiltration in abdominal aorti
CD3 and CD11b. Bar, 100 m. B,Quantitative analysis
expressed as mean  standard error of the mean for 6 raMMP-2 and MMP-9, and (4) enhanced inflammatory re-sponses. In experienced hands, the surgical procedure only
requires about 30 minutes to complete.
The elastase-induced AAA model is a standard aneu-
rysm model for in vivo research in small animals.8-12 Elas-
tase breaks down elastin, which determines the structural
and mechanical properties of aortic extracellular matrix.
Anidjar et al,7 who first established the elastase-induced
experimental aneurysm model in rats, suggested that the
main involvement of elastase in the aneurysm formation is
through enhanced elastolytic activity and a loss of elastin in
the aortic walls. Although this initial report did not clearly
mention the elastase infusion time, most laboratories have
applied a 2-hour infusion time to create the AAAs. Some
investigators have recently pointed out that the 2-hour
infusion time in this model has some drawbacks, including
high mortality related to the long elastase infusion time and
hind limb ischemia caused by the cross-clamping period of
the infrarenal aorta.13,21 We also recognized the difficulty
in keeping a constant pressure for the elastase infusion for
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pected to reduce those drawbacks, and Yamaguchi et al14
and Sinha et al15,16 have recently shown successful rat AAA
models with a 30-minute elastase infusion. Although their
procedures to form AAAs were similar to our AAA models,
the 1- to 2-mL volume of infused elastase solution in their
models was quite different from the 30-L amount in our
models. Our previous trial of the 1-mL elastase infusion
showed that the infrarenal aorta was extremely expanded,
followed by a burst of ligated lumbal branches or a rupture
of the aorta itself. Because human AAAs would not be
created by such a mechanical pressure stress, our model was
designed so that elastase was statically infused into the
clamped infrarenal aorta without any expansion. However,
our data showed that only 25% of animals with the 20-
minute elastase infusion (group E) showed successful AAAs
at 4 weeks. Carsten et al13 have suggested that some other
inflammatory modifier might be needed in the elastase-
inducedmodel to create reliable AAAs that simulate human
aneurysms.
An AAA model induced by CaCl2 is another standard
aneurysm model in small animals.2,17,22,23 An extraluminal
exposure of 0.1 to 0.5M CaCl2 was usual in most labora-
tories. The chemical damage that occurs when the outer
surface of aorta is exposed to CaCl2 promotes inflammatory
and arteriosclerotic reaction on the adventitia and subse-
quent aortic dilatation.17 A high concentration of CaCl2
produces tissue injury by an exothermic reaction around
the tissue that depends on the amount, concentration, and
the duration of exposure.24 Freestone et al25 previously
demonstrated a dose-dependent CaCl2-induced aortic in-
jury at concentrations of 0.01 to 0.5M.
In our preliminary evaluation of the viability of aortic
tissues with CaCl2 exposure ex vivo by using the Cell
Counting Kit-8 (Dojindo, Kumamoto, Japan), the differ-
ence of the viability of aortic tissues between 0.5M CaCl2
exposure and vehicle exposure was not significant (data not
shown). This result suggested that extraluminal 0.5M
CaCl2 exposure does not cause cell death resulting in
aneurysmal dilation. Although mild tissue adhesion around
the CaCl2-treated aorta was observed, no changes were
observed in the adjacent inferior vena cava such as vascular
sclerosis or dilation. In the present study, tissue injury with
inflammatory cell infiltration and proinflammatory cyto-
kine activation in the aortic wall was more severe in the
CaCl2-induced model than in the elastase-induced model.
Nevertheless, there was no AAA formation with an arbitrary
threshold of a 50% diameter increase in the CaCl2-induced
model (group C). Some other factors might be needed in
the CaCl2-induced model to create reliable AAAs.
In the AAA model in our study (group EC), elastase is
applied intraluminally and CaCl2 extraluminally. The short
incubation period of 20 minutes achieved sufficient aneu-
rysmal dilatation, with a high success rate of saccular AAA
formation at 4 weeks. Although most AAAs found in
human pathology are fusiform, saccular AAAs are thought
to be more prone to expand and rupture than fusiform
aneurysms. Because the saccular AAAs were not created ingroups C or E, we do not think that a portion of the
infrarenal rat aorta is more susceptible to structural wall
changes or that the formation of the saccular component of
the aneurysm has anything to do with the polyethylene
catheter or clamp/tie.
The reasons why elastase in the presence of CaCl2
produces mainly saccular aneurysms are assumed to be a
synergistic effect of elastase and CaCl2 that stimulates an
inflammatory response and an elastolytic cascade in the
aortic walls. Recent studies suggest that adventitial inflam-
mation in the aortic wall, in addition to wall elastolysis,
could have a detrimental role in AAA formation.23,26-28
Aortic adventitial injury due to CaCl2 induces the accumu-
lation and activation of inflammatory cells such as leuko-
cytes and T lymphocytes. Recruitment of inflammatory
cells into the aortic walls be an important source of proin-
flammatory cytokines such as TNF- and IL-1 and con-
tribute to the aneurysmal growth and rupture with subse-
quent elaboration of MMP-2 and MMP-9.2,29 MMP
upregulation due to CaCl2 as well as elastase could enhance
aortic elastin degradation synergistically. Actually, the
present study showed more infiltration of leukocytes and T
lymphocytes in the adventitia, more upregulation of
TNF-, IL-1, MMP-2, and MMP-9, and less elastin
content in group EC, leading to progressive AAA forma-
tion.
Elastase is a member of a family of serine proteases that
stimulate protease-activated receptors in aortic smooth
muscle cell, leading to the inhibition of Ca2
 influx that is
necessary for vascular contraction.30,31 This inhibition of
smooth muscle contraction may be one of factors for aortic
dilation. Furthermore, although a low concentration of
CaCl2 is a key component in Krebs solution and physio-
logic smooth muscle contractions, a high concentration of
CaCl2 might induce smooth muscle injury and then inhibit
its contractions, resulting in aneurysmal formation. The
subsequent circumferential aortic dilation would further
enhance both elastase-induced elastolysis and CaCl2-
induced injury in the aortic walls.
In the clinical settings, aneurysms typically have no
signs or symptoms, and AAA rupture has high morbidity
and mortality. There are currently no therapeutic ap-
proaches to prevent AAA, leaving patients with surgical or
endovascular therapy as their only option. Experimental
aneurysm modeling could become a powerful tool to elu-
cidate the cellular and molecular mechanisms of the AAA
pathogenesis. Targeting biologic pathways in AAA patho-
genesis may benefit patients by slowing AAA growth and
possibly preventing rupture. For these purposes, it is im-
portant to have a reliable and reproducible animal model
for AAAs that simulates true human aneurysms. The attrac-
tive features of our model are a high success rate and
optimized characteristics for aneurysm formation. Our
technique is also simpler and easier to perform, with a short
preparation time. We firmly believe that this new approach
to produce an animal AAA model can bring a better under-
standing of the mechanisms that contribute to aneurysm
JOURNAL OF VASCULAR SURGERY
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prevent or treat AAA diseases.
This study has some limitations: The first is that the
present AAA model lacks several prominent features of the
human lesion such as atherosclerosis and intraluminal
thrombosis.
Second, the present control AAA models induced by
elastase or CaCl2 are not completely similar to the conven-
tional AAA models in regard to dosage and incubation
period. We did, however, perform similar treatment condi-
tions among the study groups to compare the efficacy of
our new AAA model.
Third, we did not compare this model with other AAA
models such as angiotensin-associated, genetically predis-
posed, or hemodynamically induced aneurysms32 because
of their mechanistic differences of aneurysmal formation, or
withmouse AAAmodels because of their species difference.
Finally, the present study does not exclude the possi-
bility that subsets of collagen types, such as type I or type
III collagen, may be affected by elastase or CaCl2 applica-
tion, potentially leading to aortic structural changes and
AAA formation.
CONCLUSIONS
The novel rat AAA model we have developed using a
combination of intraluminal elastase infusion and extralu-
minal CaCl2 exposure has similarities to the human patho-
physiology of aneurysm formation. This model is simple
and easy to perform and is highly reliable and reproducible
to create a saccular aneurysm. We believe that our AAA
model is an ideal model that can be well used not only for
further research into etiopathogenetic processes leading to
the AAA development but also for the study of new diag-
nostic and therapeutic possibilities.
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